Tamoxifen administration to mice

Cold Spring Harbor Protocols

Volumn 2015, Issue 3, 2015, Pages 269-271

  Whitfield, Jonathan ^a,b   Littlewood, Trevor ^c   Soucek, Laura ^a,b  

^a VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFIMOXIFENE; TAMOXIFEN; ESTROGEN RECEPTOR; HYBRID PROTEIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANIMAL EXPERIMENT; ARTICLE; DIET; DRUG ADMINISTRATION ROUTE; MOUSE; NONHUMAN; WEIGHT REDUCTION; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; ORAL DRUG ADMINISTRATION;

ANIMALIA; MURINAE; MUS;

ADMINISTRATION, ORAL; ANIMALS; GENE EXPRESSION REGULATION; INJECTIONS, INTRAPERITONEAL; MICE; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 84924213471     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.prot077966     Document Type: Article

References (2)

1. Kiermayer C, Conrad M, Schneider M, Schmidt J, Brielmeier M. 2007. Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate. Genesis 45: 11–16.
2. Whitfield J, Littlewood T, Evan GI, Soucek L. 2014. The estrogen receptor fusion system in mouse models: A reversible switch. Cold Spring Harb Protoc. doi: 10.1101/pdb.top069815.